Buy Handelsbanken Helse Tema

Handelsbanken Helse Tema

Legal name: Handelsbanken Hälsovård Tema (A1 NOK)
Registered in Sweden (UCITS) Buy

About risk

Historical yields are not a guarantee of future returns. The money you invest in a fund can both increase and decrease in value. Future returns will depend on development in the market, the accuracy of the fund manager, the risk in the fund and management cost. It is not guaranteed that you will recover the entire invested amount. Note that a fund with risk level 5-7 stated in the fund's KID, can vary greatly in value due to the fund's composition and management methodology. The prospectus, fund rules and KIID can be obtained in English (prospectus, fund rules and KID) and Norwegian (KID) are available under each fund on handelsbanken.no/fond. The prospectus and fund rules for AIF:s are also available in Swedish. Summary of investors’ rights in English and Norwegian.

Note that Handelsbanken Fonder AB may decide to terminate the arrangements made for the marketing of funds in Norway.

Fact sheet and documents Print page
Key Investor Information Document
Factsheet 
Target Market
Costs and charges
Factsheet and Information Brochure
Prospectus (1384 kB)
Fund rules (175 kB)
Periodic reports
Sustainability SFDR (995 kB)
Annual review (PF) (3106 kB)
Semi-annual report (PF) (199 kB)
Marketing material
Summary SFDR (171 kB)
Other
Brief fund information 
The fund is actively managed and invests globally in equities issued by companies within the healthcare sector. As a result, the fund has a currency exposure to these markets. The healthcare sector refers to the pharmaceutical, medical technology, biotech, service and other healthcare-related branches.

The thematic investment strategy provides for investments that occur in a limited area in which development is deemed to result in a structural change to the economy and society. This change provides favorable conditions for companies active within the area to create profitable growth over time.

For this fund, the fund company's Enhanced exclusion level applies. For information about sectors that the fund excludes, see the Detailed information tab.

The fund is reported as an Article 9 fund pursuant to EU regulation 2019/2088 on sustainability-related disclosures in the financial services sector (SFDR).
Christopher Sundman

Fund manager

Christopher Sundman Experience in the fund industry 1987. Portfolio Manager since 1 August 2022.
Christopher Sundman

Fund manager

Caroline Banér Experience in the fund industry 2009. Portfolio Manager since 1 October 2024.
Risk: 4/7
Risk  4/7
 
The risk indicator provides guidance on the risk level for this product relative to other financial products. It shows the likelihood that the product will decrease in value due to market performance. Risk level 1 represents a low risk and risk level 7 is a high risk.
EuapIndicator:2
SFDR
 
The fund has sustainable investments as its objective. Accordingly, the fund invests in companies with products and services that are considered as contributing positively to the direct fulfillment of one or several of the targets in Agenda 2030. Refer to the fund's prospectus for additional information.
The fund is reported as an Article 9 fund pursuant to EU regulation on sustainability-related disclosures in the financial services sector (SFDR).

Read more

Graph

In percent including distribution in NOK
Compare funds
Handelsbanken Helse Tema (NOK)

Performance

Rate 02.01.2026 1 week 1 month 3 months 2026 1 year 5 years 10 years
469.17 NOK -1.20% -1.86% 7.26% -0.65% -0.39% 52.95% 180.10%

Averge annual returns (geometric)

Rate 02.01.2026 2 years 3 years 5 years 10 years
469.17 NOK 6.25% 8.05% 8.87% 10.85%

Portfolio distribution 30.11.2025

Geographic breakdown 30.11.2025

world_map